Pelandri Blog
Health insurance plan optimization — find the plan that minimizes your total annual healthcare cost.
Medigap Plan G at $158/Month vs. $0-Premium Medicare Advantage: Which Costs Less in 2026 If You Take Eliquis, Metformin, and Atorvastatin?
Medigap premiums are leaping — but switching to Medicare Advantage brings prior authorization risks and unpredictable drug copays. Here's what Eliquis, Metformin, and Atorvastatin users need to calculate before their next enrollment window closes.
Read more →Eliquis, Metformin, and Lisinopril: Why a $0-Premium Part D Plan Can Cost $437 More Per Year Than a $33/Month Plan — And What the 2027 CMS Final Rule Changes
A $0-premium Part D plan sounds like the obvious choice — until you run the numbers for Eliquis, metformin, and lisinopril. Here's exactly what three real plan structures cost annually, and what the newly released 2027 CMS Final Rule actually changes about your drug bills.
Read more →CMS 2027 Part D Final Rule Raises Plan Payments — But Eliquis Still Costs $231/Month on One Plan and $47/Month on Another: What the Policy Changes Mean for Your Drug Bills
CMS just finalized the 2027 Medicare Advantage and Part D rule — raising plan payments and relaxing marketing rules. Here's what actually changes for Eliquis, Jardiance, and Ozempic users, and why your annual drug bill still swings by $1,500 depending on which plan you pick.
Read more →Jardiance on Two $0-Premium Part D Plans: One Costs $543 More Per Year — How to Find the Cheapest Plan for Your Drug List in 2026
Two $0-premium Part D plans, the same three drugs, and a $543 annual cost difference. Here's the drug-by-drug math that shows why your Medicare premium is the least important number to check before Open Enrollment.
Read more →$35 Insulin Cap and IRA Drug Negotiations Are Real — But Picking the Wrong 2026 Part D Plan Still Costs Eliquis Users $520 More Per Year
The IRA's insulin cap and Eliquis price negotiations deliver real savings — but they don't eliminate the $520+ annual gap between Part D plans for the same drug list. Here's how the math works for 2026, and why comparing plans still matters before enrollment closes.
Read more →Eliquis Costs $144/Year With Extra Help vs $2,000 Without It: How LIS, Preferred Pharmacies, and Tier Exceptions Cut Your 2026 Part D Bill
If you take Eliquis and haven't checked your Extra Help eligibility, you may be overpaying by more than $1,800 per year. Here's how LIS, preferred pharmacy networks, mail order, and tier exceptions combine to cut your real 2026 Part D cost — with dollar-by-dollar math for a real drug list.
Read more →Generic Sitagliptin vs. Brand Januvia: Why One 2026 Part D Plan Charges $684 Per Year and Another Charges $1,622 for the Same Diabetes Drugs
Brand Januvia on a zero-premium Part D plan can cost $1,622 per year. Generic sitagliptin on the right plan costs $684. Here is how formulary tiers, prior authorization requirements, and generic substitution interact — and why your plan choice matters far more than the monthly premium.
Read more →Rosuvastatin Costs $240 Per Year on One Part D Plan and $935 on Another: How Formulary Tiers and Deductibles Determine Your Real Annual Drug Bill
The same drug list — rosuvastatin, gabapentin, omeprazole, and metoprolol — costs $702 on one Part D plan and $1,354 on another. Here's the full annual cost breakdown across three real plans, and why the plan with the lowest premium is often the most expensive choice.
Read more →Jardiance Costs $564 on One 2026 Part D Plan and $1,179 on Another — Even After the IRA Negotiated Its Price
The IRA negotiated Jardiance's price down to roughly $197/month, but your Part D plan's tier placement can still double your annual cost. Here's the drug-by-drug math across three real plans for a diabetic beneficiary in 2026.
Read more →Eliquis From $112 to $11/Month: How Extra Help, Preferred Pharmacies, and Tier Exceptions Cut Your 2026 Part D Bill Before March 31
The same Eliquis prescription costs $11/month under Extra Help and $112/month at a non-preferred pharmacy on the same plan. Here is how to use four underused Part D savings strategies before the March 31 enrollment deadline.
Read more →$9,996 Drug Bill, $2,000 Out-of-Pocket Cap: What Eliquis and Entresto Users Actually Pay Across Three Part D Plans in 2026
If you take Eliquis and Entresto together, your retail drug bill tops $9,900 a year — but the 2026 Medicare $2,000 out-of-pocket cap changes everything. Here's the full annual cost calculation across three real Part D plans, and why plan choice still shifts your total by over $600.
Read more →Turning 65 in 2026: What Metformin, Atorvastatin, and Jardiance Cost Across 3 Part D Plans — And Why Your Enrollment Window Is Only 7 Months
If you're turning 65 in 2026 and take common drugs like metformin, atorvastatin, or Jardiance, the Part D plan you pick at initial enrollment can mean a $1,100+ difference in annual drug costs — and late enrollment carries a permanent penalty. Here's how to compare before your window closes.
Read more →Ozempic Costs $100/Month on One Part D Plan and $310/Month on Another: Your 2026 GLP-1 Drug Cost Breakdown Before March 31
If you take Ozempic or Mounjaro for Type 2 diabetes, your Part D plan's formulary tier determines whether you pay $1,620 or $2,624 this year — and the Medicare Advantage Open Enrollment deadline is March 31, 2026.
Read more →Metformin, Atorvastatin, and Eliquis Cost $1,020 on One Part D Plan — and $1,540 on Another: How to Compare Drug Plans Before the March 31 Deadline
The same three-drug combination costs $520 more per year on the wrong Part D plan — and the culprit is almost never the premium. Here's a real annual cost breakdown and how to run the math for your own medications before the March 31 enrollment window closes.
Read more →Eliquis Is Now a Negotiated Medicare Drug at $231/Month: Which Part D Plan Costs You Less in 2026?
The IRA's first Medicare drug price negotiations took effect January 2026, dropping Eliquis to $231/month. But your total annual cost still swings by hundreds of dollars depending on which Part D plan you're enrolled in — here's the math across three real plans.
Read more →Eliquis + Lisinopril + Atorvastatin: Why Your Part D Plan Choice Means the Difference Between $242 and $2,000 Per Year
The same three-drug list costs $242/year on one Part D plan and $2,000 on another. Here's how Extra Help, preferred pharmacy networks, mail order, and tier exceptions determine which number you pay — and what to do before the March 31 enrollment deadline.
Read more →Medicare's $2,000 Drug Cap Explained: What Eliquis Users Actually Pay Before and After Hitting It in 2026
Medicare's new $2,000 annual out-of-pocket cap is real — but Eliquis users can still face $191/month in copays for eight months before reaching it. Here's a full annual cost breakdown across three Part D plans, and why the $0-premium plan often wins.
Read more →HDHP vs. PPO: When a High-Deductible Plan Actually Saves You Money (Calculator Inside)
Your coworker says the HDHP saved them $2,000 last year. Your friend says they got burned by one. They're both right — the break-even depends on 4 variables that are different for everyone.
Read more →The Prescription Drug Coverage Trap: How Formulary Tiers Cost You Thousands
Your plan covers your medication. But 'covered' can mean $10/month or $200/month depending on which formulary tier it lands on. Here's how to decode the system before open enrollment closes.
Read more →Medicare Plan Selection: Why Most 65-Year-Olds Choose Wrong (And How to Fix It)
There are 3,834 Medicare Advantage plans in the US. The average beneficiary has 43 options. Research shows most pick based on brand recognition, not cost — and overpay by $1,200/year as a result.
Read more →